|Articles|September 1, 2013

ACT December 2012 BPA Statement

External Link - article-822073.pdf

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato

ByLiz Beatty,Andy Studna, Senior Editor

July 7th 2026

Could Selective Safety Data Collection Become the Industry's New Default?

ByRob DiCicco,Andy Studna, Senior Editor

July 7th 2026

ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models

ByAndy Studna, Senior Editor

July 7th 2026

Why Regulator-Sponsor Alignment Is Critical to Modernizing Trial Execution

ByRob DiCicco,Andy Studna, Senior Editor

July 6th 2026

When clinical trials are designed around the "ideal" engaged patient, the populations who need new treatments most are often the ones quietly screened out before the study even begins. Credit: Stock.Adobe.com/KHAN VECTOR CO.

Operational Pragmatism in ePRO-heavy trials

ByRakshinda Mujeeb, PharmD, CRCP, ACRP-CP

July 6th 2026

ACT December 2012 BPA Statement

Related Content

AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato

Could Selective Safety Data Collection Become the Industry's New Default?

ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models

Why Regulator-Sponsor Alignment Is Critical to Modernizing Trial Execution

Operational Pragmatism in ePRO-heavy trials

Trending on Applied Clinical Trials Online

Operational Pragmatism in ePRO-heavy trials

Why Regulator-Sponsor Alignment Is Critical to Modernizing Trial Execution

Could Selective Safety Data Collection Become the Industry's New Default?

AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato

ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models